West Pharmaceutical Services Inc

Return on Assets, %

15.4

-2.7

Net income margin, %

18.7

-6.7

EBITDA margin, %

27.8

5.6

Debt to Equity, %

7.1

15.1

Intangible assets and goodwill, %

3.2

4.7

Revenue CAGR 3Y, %

11.1

12.8

Total Equity change 1Y, %

7.3

-2.4

Revenue Y, % chg

2.1

0

P/E

48.2

32.1

P/BV

9.6

2

P/S

9.4

4.1

EV/S

9.2

3.6

EV/EBITDA

32.1

7.8

Average Analyst recommendation

Buy

Buy

Average upside forecasts, %

5.2

48.9

Forward P/E

47.4

25.5

Dividend Yield, %

0.2

0.8

Forward Dividend Yield, %

0.2

0.2

Expected dividend per share

0.9

0

Payout Ratio, %

9.7

10.1

Dividend Ex Date

2024-04-23